Jun 17, 2019
Kanazawa University Research: Mapping and Measuring Proteins on the Surfaces of Endoplasmic Reticulum (ER) in Cells
Jun 03, 2019
Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa
Mar 18, 2019
Leap Therapeutics Presents at Society of Gynecologic Oncology 50th Annual Meeting on Women's Cancer
Mar 09, 2019
Hello Bio Launches Novel Water-soluble, High Potency DREADD Ligands, Licensed from the NIH
Feb 01, 2019
Alkermes Receives Complete Response Letter From U.S. Food and Drug Administration for ALKS 5461 New Drug Application
Jan 28, 2019
Kanazawa University Research: Scientists Successfully Obtain Synthetic Growth Factor Compatible to the Native Protein
Jan 10, 2019
SHAREHOLDER ALERT: Berger Montague Announces Investigation of Alkermes, plc (NASDAQ: ALKS) (CUSIP: G01767105)
Jan 08, 2019
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alkermes plc - ALKS
Jan 07, 2019
Biohaven Announces Acceptance Of Investigational New Drug (IND) Filing For Rimegepant In China
Jan 03, 2019
REVOLUTION Medicines to Present at the J.P. Morgan Healthcare Conference on January 8, 2019
Dec 27, 2018
Phoenix Molecular Designs to Present at the Biotech Showcase 2019 Conference
Dec 11, 2018
Nitrous Oxide - Global Market Outlook (2017-2026): A $1.68 Billion Opportunity - ResearchAndMarkets.com
Dec 01, 2018
Petra Pharma Presents Preclinical PIP4K2 Inhibitor Data as a Potential Treatment for Hematologic Malignancies at the 2018 American Society of Hematology Annual Meeting
Nov 15, 2018
Torrey Pines Investment's i2020 Accelerator to Advance Snap Bio's Selective Kinase Inhibitor Platform for Treatment of Endodermal Cancers and Autoimmune Diseases
Nov 01, 2018
Trading in Alkermes Ordinary Shares Halted Today
Nov 01, 2018
Alkermes Reports on Outcome of FDA Advisory Committee Meeting on ALKS 5461 for the Adjunctive Treatment of Major Depressive Disorder
Oct 29, 2018
Alkermes Announces Publication of Phase 3 Data for ALKS 5461 for Adjunctive Treatment of Major Depressive Disorder in Molecular Psychiatry
Oct 23, 2018
New Kind of Compound Shows Early Promise against Prostate Cancer
Oct 22, 2018
Reistone Biopharma, a new Chinese biotech company ready to initiate its Ulcerative Colitis phase II clinical trial globally
Sep 18, 2018
Phoenix Molecular Designs Raises $2.7M To Develop PMD-026 for Triple-Negative Breast Cancer (TNBC)